<DOC>
	<DOCNO>NCT00228930</DOCNO>
	<brief_summary>The purpose research try identify woman take tamoxifen likely suffer hot flash likely side effect benefit drug . The researcher determine whether mutation normally occur human DNA might influence way individual respond medication .</brief_summary>
	<brief_title>Tamoxifen Pharmacogenetics Clinical Effects</brief_title>
	<detailed_description>The study test follow hypothesis . 1 . There relationship genetically distinct metabolic profile tamoxifen frequency severity hot flash woman chronic tamoxifen therapy . 2 . Genetically distinct metabolic profile tamoxifen effect lipid profile , bone turnover metabolites bone mineral density , coagulation factor . 3 . Different genetic profile estrogen responsive gene influence pharmacodynamic effect tamoxifen cardiovascular system .</detailed_description>
	<mesh_term>Tamoxifen</mesh_term>
	<criteria>1 . 18years old 2 . Women prior breast cancer high risk develop disease start tamoxifen therapy . 3 . Participants must treat concomitant chemotherapy hormone therapy tamoxifen . They must ovarian ablation currently treat radiation therapy and/or chronic corticosteroid . 4 . The participant must take antihot flash therapy ( clonidine , bellergal , megestrol acetate ) . Vitamin E , selective serotonin reuptake inhibitor , herbal remedy allow provide participant take remedy least 4 week intend continue remedy least first month study , allow onemonth follow evaluation ( hot flash diary blood sample ) . 5 . The participant must pregnant lactating . 6 . The participant able willing sign inform consent .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>Breast Cancer</keyword>
	<keyword>Tamoxifen</keyword>
	<keyword>Prevention</keyword>
</DOC>